Zhang et al. showed that in PCOS rats, the therapy effect of berberine in reducing PCOS pathology and IR values is associated with a mechanism linked to GLUT4 upregulation via PI3K/Akt activation and MAPK pathway suppression [33]. The gene discussed is AKT1; the disease is polycystic ovary syndrome.